In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species.
The susceptibility of clinical isolates of Escherichia coli (67) and Proteus species (58) to cephalothin, ampicillin, benzyl penicillin, and phenoxymethyl penicillin was determined in vitro by using broth dilution and disk diffusion tests. The data were correlated by using a four-category scheme for interpreting minimal inhibitory concentrations (groups 1 to 4) as recommended by a subcommittee of an international collaborative study of susceptibility testing. With cephalothin and ampicillin, groups 1 (susceptible) and 2 (moderately susceptible) were susceptible by the disk test, and with benzyl penicillin, similar results were observed when the interpretive zone standards were changed. Strains categorized as group 4 (very resistant) were resistant by the disk method, but group 3 (moderately resistant) strains were not adequately distinguished by disk testing. Group 3 susceptibility to benzyl and phenoxymethyl penicillins can be predicted by extrapolating results from tests with ampicillin disks.
D000667:Ampicillin / Q000494:pharmacology; D002512:Cephalothin / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects*; D008722:Methods; D008826:Microbial Sensitivity Tests; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D010404:Penicillin V / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology*; D011511:Proteus / Q000187:drug effects*; D011513:Proteus mirabilis / Q000187:drug effects; D011514:Proteus vulgaris / Q000187:drug effects
D010406:Penicillins; D000667:Ampicillin; D010400:Penicillin G; D002512:Cephalothin; D010404:Penicillin V